Clinical Correlates
and Mortality of Hemodynamically Significant Tricuspid Regurgitation
Carolyn Z. Behm, Jayant Nath, Elyse Foster
Department of Medicine, Division of Cardiology,
University of California San Francisco, San Francisco, CA, USA |
Background and aim of study: Limited data exist
regarding the etiologies and prognostic significance of severe tricuspid
regurgitation (TR) in the modern medical era. This retrospective chart
review examines the causes of, and mortality associated with, hemodynamically
significant TR.
Methods: The database of the echocardiography laboratory
at a major academic medical center was searched from August 2000
to October 2001, identifying 91 patients (1.2%) with transthoracic
echocardiograms demonstrating moderate-severe or severe TR. A total
of 77 available charts was reviewed retrospectively for medical
history, examination and electrocardiogram findings. The underlying
cause of each patient’s TR was determined by compiling data
from the chart and echocardiogram. All deaths were recorded from
the date of echocardiography until September 2002.
Results: A cause for TR was determined in 96% of patients.
Functional TR due to right ventricular pressure or volume |
overload was found in 85.5% of patients, while 14.5% had
primary TR due to organic abnormalities of the tricuspid valve leaflets.
Conditions associated with significant TR included pulmonary hypertension
(46%), ischemic cardiomyopathy (25%), non-ischemic dilated cardiomyopathy
(8%), Ebstein’s anomaly (4%), rheumatic heart disease (4%), endocarditis
(4%), tricuspid valve prolapse (2%), and severe mitral valve disease
(2%). Of 37 patients (44.6%) who died, 17 (21%) did so within one month
of the echocardiogram.
Conclusion: Among patients presenting to a tertiary medical
center, hemodynamically significant TR was more commonly functional
than due to organic tricuspid valve disease. The most frequently
associated diseases included pulmonary hypertension and cardiomyopathy.
Significant TR may be a marker of increased mortality risk as it
reflects the severity of underlying disease. Further studies in
this area are warranted.
The Journal of Heart Valve Disease 2004;13:784-789 |